Denali Therapeutics Stock Price on November 5, 2024
| DNLI Stock | USD 24.69 0.47 1.94% |
Below is the normalized historical share price chart for Denali Therapeutics extending back to December 08, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Denali Therapeutics stands at 24.69, as last reported on the 25th of November, with the highest price reaching 24.73 and the lowest price hitting 23.97 during the day.
If you're considering investing in Denali Stock, it is important to understand the factors that can impact its price. Denali Therapeutics is very steady at the moment. Denali Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0118, which denotes the company had a 0.0118% return per unit of risk over the last 3 months. We have found thirty technical indicators for Denali Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Denali Therapeutics' Downside Deviation of 3.67, mean deviation of 2.35, and Coefficient Of Variation of 3174.18 to check if the risk estimate we provide is consistent with the expected return of 0.0402%.
As of now, Denali Therapeutics' Stock Based Compensation is increasing as compared to previous years. The Denali Therapeutics' current Stock Based Compensation To Revenue is estimated to increase to 0.63, while Total Stockholder Equity is projected to decrease to under 712.9 M. . The Denali Therapeutics' current Price Earnings To Growth Ratio is estimated to increase to 0.36, while Price To Sales Ratio is projected to decrease to 8.47. Denali Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of December 2017 | 200 Day MA 22.6171 | 50 Day MA 27.8774 | Beta 1.394 |
Denali |
Sharpe Ratio = 0.0118
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DNLI |
Estimated Market Risk
| 3.42 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Denali Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Denali Therapeutics by adding Denali Therapeutics to a well-diversified portfolio.
Price Book 2.6951 | Enterprise Value Ebitda (8.66) | Price Sales 3.3 K | Shares Float 130.1 M | Wall Street Target Price 41.6923 |
Related Headline
Stoke Therapeutics Headline on 5th of November 2024
Vanguard Group Incs Strategic Acquisition in Stoke Therapeut... by gurufocus.com
Overview of Vanguards Recent Transaction On September 30, 2024, Vanguard Group Inc made a notable addition to its investment portfolio by acquiring 71,589 shar
Denali Therapeutics Valuation on November 5, 2024
It is possible to determine the worth of Denali Therapeutics on a given historical date. On November 5, 2024 Denali was worth 26.17 at the beginning of the trading date compared to the closed value of 27.65. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Denali Therapeutics stock. Still, in general, we apply an absolute valuation method to find Denali Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Denali Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Denali Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 26.91 | 27.63 | 26.76 | 27.21 | 607,245 | |
11/05/2024 | 26.17 | 27.70 | 26.17 | 27.65 | 556,620 |
| 28.98 | 29.60 | 28.23 | 29.55 | 1,031,187 |
| Backtest Denali Therapeutics | | | Denali Therapeutics History | | | Denali Therapeutics Valuation | Previous | Next |
Denali Therapeutics Trading Date Momentum on November 5, 2024
| On November 06 2024 Denali Therapeutics was traded for 29.55 at the closing time. The top price for the day was 29.60 and the lowest listed price was 28.23 . The trading volume for the day was 1 M. The trading history from November 6, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 6.87% . The overall trading delta against the current closing price is 2.64% . |
Denali Therapeutics Fundamentals Correlations and Trends
By evaluating Denali Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Denali Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Denali financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Denali Therapeutics Stock history
Denali Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Denali is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Denali Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Denali Therapeutics stock prices may prove useful in developing a viable investing in Denali Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 137.4 M | 86.7 M | |
| Net Loss | -293.4 M | -278.7 M |
Denali Therapeutics Quarterly Net Working Capital |
|
Denali Therapeutics Stock Technical Analysis
Denali Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Denali Therapeutics Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Denali Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Denali Therapeutics November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Denali Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Denali Therapeutics shares will generate the highest return on investment. By undertsting and applying Denali Therapeutics stock market strength indicators, traders can identify Denali Therapeutics entry and exit signals to maximize returns
Denali Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Denali Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Denali Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Denali to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0319 | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.44) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.04 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |